Insight into the relationship between forced vital capacity and transfer of the lungs for carbon monoxide in patients with idiopathic pulmonary fibrosis

被引:0
|
作者
Soumagne, Thibaud
Quetantb, Sebastien [2 ]
Guillien, Alicia [3 ]
Falque, Loic [2 ]
Hess, David [4 ]
Aguilaniu, Bernard [4 ,5 ]
Degano, Bruno [1 ,6 ,7 ]
机构
[1] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Pneumol & Reanimat Resp, Clamart, France
[2] Ctr Hosp Univ Grenoble Alpes, Serv Hosp Univ Pneumol Physiol, Pole Thorax & Vaisseaux, Grenoble, France
[3] Univ Grenoble Alpes, Inst Avancee Biosci IAB, Epidemiol Environm Appl Reprod & Sante Resp, INSERM,CNRS,U1209, Grenoble, France
[4] Assoc Complementar Connaissances & Prat Pneumol a, Programme Colibri, 19 Ave Marcelin Berthelot, F-38100 Grenoble, France
[5] Univ Grenoble Alpes, Grenoble, France
[6] Univ Grenoble Alpes, Lab HP2, INSERM U1300, Grenoble, France
[7] CHU Grenoble Alpes, Serv Hosp Univ Pneumol Physiol, F-38043 Grenoble, France
来源
关键词
Idiopathic pulmonary fibrosis; Pulmonary function tests; Forced vital capacity; Transfer of the lungs for carbon monoxide; Introduction; CLINICAL-PRACTICE; REFERENCE VALUES; DISEASE; PREDICTION; DIAGNOSIS; SURVIVAL; DLCO; KCO; FVC;
D O I
10.1016/j.resmer.2023.101042
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Forced vital capacity (FVC) is routinely used to quantify the severity and identify the progression of idiopathic pulmonary fibrosis (IPF). Although less commonly used, lung transfer of carbon monoxide (TLCO) correlates better with the severity of IPF than does FVC.Methods: Aiming at studying how FVC behaves in relation to TLCO, we analysed cross-sectional data from 430 IPF patients, of which 221 had at least 2 assessments (performed 2.4 +/- 1.9 years apart) available for longitudinal analyses. Thresholds for identifying "abnormal" FVC and TLCO values were the statistically-defined lower limits of normal (LLN). For patients with longitudinal data, mean annual absolute declines of FVC and TLCO were calculated. Results: The correlation between FVC and TLCO (%predicted) was weak (R2=0.21). FVC was "abnormal" (i.e., 38% of patients while 84% of patients had an "abnormal" TLCO. A large majority of the 268 patients with a "normal" FVC had nevertheless an "abnormal" TLCO (n = 209; 78%). On longitudinal analysis, 67/221 patients had an annual absolute decline in FVC >= 5%, 34/221 had an annual absolute decline in TLCO >= 10%, and 22 had both.Conclusion: In IPF, a "normal" FVC should be viewed with caution as it is most often associated with an "abnormal" TLCO, a parameter that is strongly correlated with the morphological extent of the disease. Only 1/3 of the patients with a FVC-based progression criterion also had a TLCO progression criterion. In contrast, 2/3 of patients with a TLCO progression criterion also had a FVC progression criterion.(c) 2023 Published by Elsevier Masson SAS.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Relationship Between MRNA-microRNA Interactions and Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
    Noth, I.
    Roy, J.
    Schmid, R.
    Vinisko, R.
    Strobel, B.
    Neely, M. L.
    Hesslinger, C.
    Belperio, J. A.
    Flaherty, K. R.
    Salisbury, M. L.
    Oldham, J.
    Palmer, S. M.
    Todd, J. L.
    Leonard, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [2] The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis
    Assayag, D.
    Vittinghoff, E.
    Ryerson, C. J.
    Cocconcelli, E.
    Tonelli, R.
    Elicker, B.
    Golden, J.
    Jones, K. D.
    King, T. E.
    Koth, L. L.
    Lee, J. S.
    Ley, B.
    Wolters, P. J.
    Collard, H. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [3] Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis
    Flaherty, Kevin R.
    Kolb, Martin
    Vancheri, Carlo
    Tang, Wenbo
    Conoscenti, Craig S.
    Richeldi, Luca
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (02)
  • [4] The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis
    Assayag, Deborah
    Vittinghoff, Eric
    Ryerson, Christopher J.
    Cocconcelli, Elisabetta
    Tonelli, Roberto
    Hu, Xiaowen
    Elicker, Brett M.
    Golden, Jeffrey A.
    Jones, Kirk D.
    King, Talmadge E., Jr.
    Koth, Laura L.
    Lee, Joyce S.
    Ley, Brett
    Shum, Anthony K.
    Wolters, Paul J.
    Ryu, Jay H.
    Collard, Harold R.
    RESPIRATORY MEDICINE, 2015, 109 (08) : 1058 - 1062
  • [5] Reference values for forced vital capacity in idiopathic pulmonary fibrosis
    Pereira, Carlos A. C.
    RESPIRATORY MEDICINE, 2017, 125 : 102 - 102
  • [6] The Single Breath Diffusing Capacity for Carbon Monoxide in Patients with Idiopathic Pulmonary Fibrosis: 6 Month Variability and Its Role in Predicting Forced Vital Capacity Change
    Nathan, S. D.
    Yang, M.
    Stauffer, J. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] Associations Between Hospitalization And Forced Vital Capacity Endpoints And Survival In Idiopathic Pulmonary Fibrosis
    Durheim, M. T.
    Collard, H. R.
    Roberts, R. S.
    Brown, K. K.
    Flaherty, K. R.
    King, T. E.
    Palmer, S. M.
    Raghu, G.
    Snyder, L. D.
    Anstrom, K. J.
    Martinez, F. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [8] Composite Physiologic Index, Percent Forced Vital Capacity and Percent Diffusing Capacity for Carbon Monoxide Could Be Predictors of Pirfenidone Tolerability in Patients with Idiopathic Pulmonary Fibrosis
    Konishi, Satoshi
    Arita, Machiko
    Ito, Isao
    Tachibana, Hiromasa
    Takaiwa, Takuya
    Fukuda, Yasushi
    Watanabe, Naoki
    Tsubouchi, Kazuya
    Masuda, Gen
    Tanaka, Maki
    Kourogi, Youhei
    Kunimasa, Kei
    Nishiyama, Akihiro
    Iwasaku, Masahiro
    Ito, Akihiro
    Tokioka, Fumiaki
    Yoshioka, Hiroshige
    Hashimoto, Toru
    Ishida, Tadashi
    INTERNAL MEDICINE, 2015, 54 (22) : 2835 - 2841
  • [9] Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis
    Watanabe, Kentaro
    Nagata, Nobuhiko
    Kitasato, Yasuhiko
    Wakamatsu, Kentaro
    Nabeshima, Kazuki
    Harada, Taishi
    Hirota, Takako
    Shiraishi, Motokimi
    Fujita, Masaki
    RESPIRATORY INVESTIGATION, 2012, 50 (03) : 88 - 97
  • [10] Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis
    Pesonen, Ida
    Gao, Jing
    Kalafatis, Dimitrios
    Carlson, Lisa
    Myllarniemi, Marjukka
    Ferrara, Giovanni
    Skold, Magnus
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52